These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28554075)

  • 21. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
    Song HR; Kweon SS; Kim HN; Piao JM; Yun WJ; Choi JS; Hwang JE; Yoon JY; Kim HR; Park YK; Kim SH; Choi YD; Shin MH
    Gastric Cancer; 2011 Aug; 14(3):242-8. PubMed ID: 21461655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
    Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
    J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
    Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
    Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
    Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
    Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 72Pro Variant of the Tumor Protein 53 Is Associated with an Increased Breast Cancer Risk in the Moroccan Population.
    Ayoubi SE; Elkarroumi M; El Khachibi M; Hassani Idrissi H; Ayoubi H; Ennachit S; Arazzakou M; Nadifi S
    Pathobiology; 2018; 85(4):247-253. PubMed ID: 29949804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population.
    Camargo-Kosugi CM; D'Amora P; Kleine JP; Carvalho CV; Sato H; Schor E; Silva ID
    Genet Mol Res; 2014 Aug; 13(3):6503-11. PubMed ID: 25177931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers.
    Sonoyama T; Sakai A; Mita Y; Yasuda Y; Kawamoto H; Yagi T; Yoshioka M; Mimura T; Nakachi K; Ouchida M; Yamamoto K; Shimizu K
    Mol Med Rep; 2011; 4(3):489-95. PubMed ID: 21468597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
    Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
    Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
    Dastjerdi MN
    Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
    Khan MS; Pandith AA; Masoodi SR; Khan SH; Rather TA; Andrabi KI; Mudassar S
    Cancer Biomark; 2015; 15(4):459-65. PubMed ID: 25835179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
    Rahman MA; Hasan MM; Hossain A; Alam KM; Sultana R; Mazid MA; Rahman MM
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2361-2368. PubMed ID: 37505767
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
    J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients.
    Zemleduch T; Lianeri M; Rydzanicz M; Gajecka M; Szyfter K; Jagodziński PP
    Oral Oncol; 2009 Aug; 45(8):683-6. PubMed ID: 19091625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.